Galmed Pharmaceuticals (GLMD) Amortizatization of Intangibles (2015 - 2025)
Galmed Pharmaceuticals (GLMD) recorded quarterly Amortizatization of Intangibles of -$6000.0 in Q4 2025, down 220.0% quarter-over-quarter from $5000.0 in Q3 2025.
Galmed Pharmaceuticals (GLMD) Amortizatization of Intangibles (2015 - 2025) Analysis & Trends
Galmed Pharmaceuticals' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at -$6000.0 for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles changed N/A year-over-year to -$6000.0; the TTM figure through Dec 2025 stood at $15000.0 (changed N/A YoY), while the FY2025 annual figure was $15000.0, up 188.24% from the prior year.
- Amortizatization of Intangibles was -$6000.0 for Q4 2025 at Galmed Pharmaceuticals, down from $5000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $105000.0 in Q2 2021 to a low of -$59000.0 in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $9937.5 across 5 years, with a median of $5500.0 in 2021.
- The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles sank 1083.33% in 2022, then surged 466.67% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $6000.0 in 2021, then tumbled by 1083.33% to -$59000.0 in 2022, then soared by 106.78% to $4000.0 in 2023, then surged by 50.0% to $6000.0 in 2024, then tumbled by 200.0% to -$6000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at -$6000.0 (Q4 2025), $5000.0 (Q3 2025), and -$18000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | -6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | -59,000.00 |
| Dec 31, 2022 | -59,000.00 |
| Sep 30, 2022 | 22,000.00 |
| Sep 30, 2022 | 22,000.00 |